Work

AZURE: A Phase 1/2 Study of Blu-263 As Monotherapy and in Combination with Azacitidine in Patients with Advanced Systemic Mastocytosis

Year: 2022

Type: article

Source: Blood

DOI: 10.1182/blood-2022-167410

Authors: Daniel J. DeAngelo, Andreas Reiter, Tracy I. George, Deepti H. Radia, Marissa Devlin, Saša Dimitrijević, Mikael Rinne, Robyn Scherber, Jason Gotlib

Institutions: Dana-Farber Cancer Institute, University Medical Centre Mannheim, ARUP Laboratories (United States), Guy's Hospital, Guy's and St Thomas' NHS Foundation Trust, Blueprint Medicines (United States), Stanford Medicine, Stanford Cancer Institute, Stanford University

Language: English

Topic: Mast cells and histamine

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310108165

FWCI: 1.242

Cites:

Cited by: 13

Related to: 10